SOMATEX Medical Technologies GmbH
Somatex_Medical-Technologies-GmbH   Somatex_Medical-Technologies-GmbH
Deutsch English  Pусский 
Newsletter Contact Press
Development without compromises
Biopsy Drainage Hematology - Oncology LITT Mammography MRI Devices Antenatal Diagnostics Special Products Vertebroplasty
Press
PRESS RELEASES
SOMATEX® Medical Technologies among the TOP 100 Enterprises

Medical technology company located in Teltow wins prize for being one of the most innovative medium-sized companies in Germany

Teltow, June 27, 2005. The company SOMATEX® Medical Technologies achieved the quality seal ”TOP 100” for its excellent innovative accomplishments. The award was given to the company by TOP 100 patron Lothar Späth on June 22, 2005, at the awards ceremony at the Grand Hyatt Hotel in Berlin.

The quality seal ”Top 100” is awarded annually in the framework of a Germany-wide comparison study analysing innovation results and innovation management of medium-sized companies. The study is carried out by Prof. Dr. Nikolaus Franke from the Vienna University of Economics.

Somatex, ausgezeichneter Innovator im deutschen Mittelstand
www.top100.de

SOMATEX® Medical Technologies represents one of only eight companies located in the new federal German states that managed to be listed among the hundred most innovative medium-sized enterprises in Germany. The study particularly stresses the excellent innovation climate at SOMATEX: ”The company’s employees submit more suggestions for improvement than the average of the TOP 100 firms.” According to the study, this proves that the company has recognized the great innovative potential of its employees and makes use of it accordingly. Another positive aspect has been - among others - that a fixed budget is set aside for highly innovative, but risky projects (internal venture capital).

”This award strongly further motivates us to constantly look for new medical technology solutions in order to improve existing clinical treatment methods or to make new treatment methods possible at all”, says Frank Kniep, General Manager of SOMATEX® Medical Technologies.

Information on SOMATEX® 
The company SOMATEX® Medical Technologies GmbH specializes in the development and manufacturing of disposable minimally invasive instruments in the areas of tumor ablation, vertebroplasty, biopsy and oncology.
In addition to the manufacturing of standard instruments for diagnostic and therapeutical procedures, SOMATEX® develops innovative special products and new instruments based on what treating physicians precisely need. Since 1992, the company constantly develops new medical therapy concepts and realizes them in their products in close cooperation with physicians, hospitals and university clinics. Its focus is set on methods and instruments allowing minimally invasive operations using magnetic resonance imaging. In the past few years, the SOMATEX® has also intensified its activities aiming at the development of new procedures and instruments used to treat painful vertebral compression fractures, for example caused by osteoporosis.

No fees to be paid for publication. Please send specimen copy to:

Press Contact
unlimited communications berlin
Mr. Torsten Krüger
Rosenthalerstr. 40/41
D-10178 Berlin
Tel. 030 / 280078-63
E-Mail: tkrueger@ucm.de

Contact SOMATEX
SOMATEX Medical Technologies GmbH
Ms. Anja Schlicht
Rheinstr. 7d
D-14513 Teltow
Tel +49 (0) 3328 / 30 76-12
E-Mail: a.schlicht@SOMATEX.com

Biopsy Drainage Hematology LITT Mammography MRI Antenatal Diagn. Special Vertebroplasty
    

Information provided in this site is not intended to be used by physicians, other health care providers or patients in the United States of America. SOMATEX Medical Technolgies GmbH disclaims any liability for the acts in the United States of America of any physicians or any other individual or group acting independently or on behalf of any organization who receive any information on any medical product or procedure through this web site. SOMATEX Medical Technologies GmbH accepts no legal responsibility for any injury and/or damage to persons or property occurring in the United States of America as a result of any of the methods, products, instructions, suggestions, or ideas contained or discussed herein.